QVAR REDIHALER (nda207921)- (0.04MG/INH,0.08MG/INH)

Generic Name	BECLOMETHASONE DIPROPIONATE	Innovator	NORTON WATERFORD
Dosage	0.04MG/INH,0.08MG/INH
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2041-Aug-19	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	QVAR REDIHALER is a corticosteroid indicated for: • Maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	4

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.04MG/INH	**	**	Up	-	-
0.08MG/INH	**	**	Up	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of QVAR REDIHALER